Virta Health reports improved outcomes in pancreatic cancer trial
The trial enrolled patients who received a triplet chemotherapy regimen of nab-paclitaxel, cisplatin, and gemcitabine.
Clinical Trials
Pilatus Biosciences doses first patient in PLT012 antibody trial
Patient enrolment concludes in Spinogenix’s Phase II schizophrenia trial
Gesynta Pharma doses first patient in Phase II NOVA trial
EnteroBiotix completes enrolment in Phase IIa MAST trial
Kainova reports positive top line results from Phase I EPRAD trial
Veru enrols first patient in Phase IIb trial of enobosarm and semaglutide combo
AbbVie reports topline data from Phase I ABBV-295 trial
